GPT and metabolic dysfunction-associated steatotic liver disease: Elevated ALT level and a low AST/ALT ratio suggest nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, increasing the risk of liver cirrhosis and hepatocellular carcinoma [28, 29].